Clinical Trials Sponsored by Austrian Breast & Colorectal Cancer Study Group (ABCSG)

Total 27 results

AstraZeneca
Austrian Breast and Colorectal Cancer Study Group (ABCSG)

Recruiting

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) (CAMBRIA-2)

Breast Cancer, Early Breast Cancer

United States, Spain, Italy, Belgium, Canada, Korea, Republic of, Portugal, France, United Kingdom, China, Germany, Japan, Mexico, Thailand, Australia, Austria, Brazil, Colombia, Taiwan, Malaysia, Philippines, Poland, Romania, Chile, Sw... and more
Austrian Breast & Colorectal Cancer Study Group

Completed

Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma

Colorectal Carcinoma

Austria
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

Colon Cancer Stage II

Austria
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

Colon Cancer Stage III

Austria
Austrian Breast & Colorectal Cancer Study Group

Completed

Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients

Early Stage Breast Cancer
Austrian Breast & Colorectal Cancer Study Group

Terminated

Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C

Rectal Cancer Dukes B, Dukes C

Austria
Austrian Breast & Colorectal Cancer Study Group
Pharmacia Austria GmbH

Completed

Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane

Breast Cancer

Austria
Austrian Breast & Colorectal Cancer Study Group
AstraZeneca

Completed

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

Early-stage Breast Cancer
Austrian Breast & Colorectal Cancer Study Group
AstraZeneca

Completed

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

Early-stage Breast Cancer
Austrian Breast & Colorectal Cancer Study Group
Merck Gesellschaft mbH, Austria

Terminated

A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis (G-LUCAS)

Colorectal Cancer | Steatohepatitis

Austria
Austrian Breast & Colorectal Cancer Study Group
Oberösterreichische Krebshilfe

Recruiting

ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer (ABCSG C08)

Colorectal Carcinoma

Austria
Amgen
Austrian Breast and Colorectal Cancer Study Group

Completed

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Breast Cancer

Austria, Sweden
German Breast Group
Novartis Pharmaceuticals; Austrian Breast & Colorectal Cancer Study Group

Completed

Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy (NATAN)

Breast Cancer

Germany, Austria
Austrian Breast & Colorectal Cancer Study Group
AstraZeneca; Novartis Pharmaceuticals

Completed

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Breast Cancer

Austria, Germany
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche

Terminated

Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy

Rectal Cancer

Austria
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche

Completed

Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy

Rectal Cancer

Austria
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche; Merck Gesellschaft mbH, Austria

Completed

Preoperative Chemoradiation With Capecitabine and Cetuximab

Rectal Cancer

Austria
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche; Cephalon

Completed

A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer (ABCSG 32)

Breast Cancer

Austria
Karolinska University Hospital
German Breast Group; Austrian Breast & Colorectal Cancer Study Group; Swedish...

Unknown

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients (PANTHER)

Breast Cancer

Sweden, Germany, Austria
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche; Sanofi-Synthelabo

Completed

Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma

Rectal Cancer

Austria
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Austrian Breast & Colorectal Cancer Study...

Recruiting

Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation (BRCA-P)

Neoplasms | Breast Cancer | Breast Neoplasms | Breast Diseases | Breast Carcinoma | BRCA1 Mutation

United States
German Breast Group
Gilead Sciences; ETOP IBCSG Partners Foundation; UNICANCER; Austrian Breast & Colorectal... and other collaborators

Recruiting

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer (SASCIA)

Triple Negative Breast Cancer | HER2-negative Breast Cancer

Spain, France, Germany, Austria, Belgium, Ireland, Italy, Switzerland
Genentech, Inc.
Breast International Group; SOLTI Breast Cancer Research Group; Austrian Breast...

Completed

A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)

Breast Cancer

United States, United Kingdom, Germany, Australia, Austria, Belgium, Brazil, France, Guatemala, Italy, Korea, Republic of, Panama, Poland, Portugal, Spain, Czechia, Hungary, Mexico, Peru, Switzerland, El Salvador, Chile
Austrian Breast & Colorectal Cancer Study Group
Sanofi; Hoffmann-La Roche; Amgen; Ebewe Pharma GmbH

Completed

Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer

Breast Cancer

Austria
University Hospital, Basel, Switzerland
ETOP IBCSG Partners Foundation; Austrian Breast Cancer Study Group

Recruiting

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS) (TAXIS)

Node-positive Breast Cancer

Greece, Switzerland, Hungary, Austria, Germany, Italy, Lithuania, Argentina, Croatia
Alliance Foundation Trials, LLC.
Pfizer; Breast International Group; NSABP Foundation Inc; Austrian Breast & Colorectal... and other collaborators

Active, not recruiting

PALbociclib CoLlaborative Adjuvant Study (PALLAS)

Breast Cancer

United States, Spain, Italy, Ireland, United Kingdom, Australia, Germany, Japan, Portugal, Taiwan, Canada, Israel, Netherlands, Switzerland, Belgium, Austria, Hungary, Korea, Republic of, Mexico, Poland, Sweden
Austrian Breast & Colorectal Cancer Study Group
Bayer; GlaxoSmithKline; Merck Sharp & Dohme LLC; Hoffmann-La Roche; AstraZeneca; Amgen and other collaborators

Completed

Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer (POSYTIVE)

Circulating Tumor Cells | Synchronous Metastasized Breast Cancer

Austria

Clinical Trials Sponsored by Austrian Breast & Colorectal Cancer Study Group (ABCSG)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations